NTI 4.76% 11.0¢ neurotech international limited

In-home Mente autism device for use in adults

  1. 1,528 Posts.
    lightbulb Created with Sketch. 93
    Hey guys did anyone go back and review Neurotech's Cambridge University Presentation back in September? Link here:

    https://www.asx.com.au/asxpdf/20170928/pdf/43mq004nq4l9rp.pdf

    The reason why I state this is because it appears NTI Neurotech may be attempting to utilise in-home Mente autism devices in adults in addition to children to widen their market. Potentially 1:68 of the normal population has autism thereby opening Mente autism to a much wider potential market.

    Dr Emanuela Russo reported to Cambridge in September 2017 that when neurofeedback was utilised in a Nineteen year old patient with autism analyses indicated a number of trends in expected directions and some significant effects.

     Delta decrease in Frontal and Centro-temporal areas toward normalization
     Beta decrease in Frontal and Centro-temporal areas toward normalization
     Alpha towards normalization

    This would suggest that Neurotech has the ability to conduct a second study for the use of Neurofeedback in adults.

    Neurofeedback expanded to young adults..PNG
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
11.0¢
Change
0.005(4.76%)
Mkt cap ! $100.9M
Open High Low Value Volume
10.5¢ 11.0¢ 10.3¢ $181.1K 1.695M

Buyers (Bids)

No. Vol. Price($)
4 200400 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 120696 2
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
10.5¢
  Change
0.005 ( 6.06 %)
Open High Low Volume
10.3¢ 11.0¢ 10.0¢ 611824
Last updated 15.56pm 29/03/2024 ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.